期刊文献+

结核病Mtb8.4/hIL-12嵌合基因疫苗免疫保护效果研究 被引量:6

Study on the protective effecacy of Mtb8.4/hIL-12 chimeric gene vaccine
暂未订购
导出
摘要 目的研究Mtb8.4/hIL-12嵌合基因疫苗的免疫原性及对小鼠结核杆菌感染的免疫保护效果。方法将雌性C57BL/6N小鼠40只,随机分为5组,即Mtb8.4/hIL-12嵌合基因、Mtb8.4基因疫苗组、BCG组、空载体组和PBS组。小鼠脾细胞培养上清液检测细胞因子水平;并按效靶比例分别为100∶1、50∶1、10∶1进行细胞毒性T细胞(CTL)杀伤检测。用结核杆菌H37Rv强毒株静脉攻击小鼠,计数肺和脾组织中的结核杆菌菌落数,对小鼠部分肺和脾组织作病理切片,HE染色观察组织病变程度,Z-N染色查抗酸杆菌,观察该疫苗对小鼠结核杆菌感染的免疫保护效果。结果Mtb8.4/hIL-12嵌合基因疫苗对小鼠结核杆菌感染有一定的免疫保护效果,能够诱导较强的抗原特异性Th1型细胞免疫应答,细胞因子IFN-γ和IL-2分泌增加,IL-4分泌减少,特异性CTL活性增加;使小鼠肺和脾组织中的结核杆菌菌落数较空载体组显著减少,组织病变明显减轻,其效果优于卡介苗(BCG)组和Mtb8.4基因疫苗组。结论hIL-12与Mtb8.4构建成嵌合基因疫苗后,使Mtb8.4基因疫苗的免疫效力得到很大提高。 Objective To study the immunogenicity and protective effecacy of Mtb8.4/hIL-12 chimeric gene vaccine. Methods 40 C57BL/6N mice were divided into 5 groups: Mtb8.4/hlL-12 chimeric gene vaccine, Mtb8.4 gene vaccine, BCG, empty vector alone and PBS. Mice were vaccinated intramuscularly in both hind limbs three times at the intervals of three weeks or once subcutaneously with 1× 10^6 of viable M, bovis BCG Pasteur at the time of the first DNA immunization, 4 weeks after the final inoculation, three mice were sacrificed to assess cytokine response and CTL induction and the other five mice were challenged intravenously in a lateral tail vein with 1 × 10^6 CFU of virulent M, tuberculosis H37Rv. Spleen and the left lung were harvested from each mouse at 4 weeks after infection and honlogenized in sterile saline. Serial dilutions of organ homogenates were plated on L-J agar and incubated 37℃ until colonies were visible 4 weeks later. Protective efficacies in each experiment were expressed as reduced CFU and were compared with the negative control group. The right lung was obtained from each mouse and inflated with and stored in 10% formahn saline immediately. Tissues were embedded in paraffin, sectioned and stained with hematoxylin and eosin. Results Mtb8.4/hIL-12 chime-ric gene vaccine induced the secretion of more ofThl cytokines, but not IL-4 and enhanced CTL activity while BCG induced the secretion of both types of cytokines (IFN-γ, IL-2 and IL-4). Mice immunized with Mtb8.4/hIL-12 chimeric gene vaccine had fewer and smaller tubercles than control groups. As expected, control mice had the highest bacterial loads in both lung and spleen. Immuization with Mtb8.4/hIL-12 chimeric gene vaccine could remarkably reduced CFU counts in organs. Conclusion When it was used to construct the chimeric gene vaccine, hIL-12 could improve the immune efficacy of Mtb8.4 gene vaccine. Protective efficacy
出处 《免疫学杂志》 CAS CSCD 北大核心 2007年第2期139-143,共5页 Immunological Journal
基金 四川省青年科技基金资助([2002]1号)
关键词 结核病 Mtb8.4/hIL-12 嵌合基因 基因疫苗 免疫保护 Tuberculosis Mtb8.4/hIL-12 Chimeric gene Gene vaccine Protective efficacy
  • 相关文献

参考文献13

二级参考文献42

  • 1程继忠,皇甫永穆.重组BCG疫苗的研究进展[J].微生物学杂志,1996,16(4):47-50. 被引量:10
  • 2金冬雁 黎盂枫 等译.大肠杆菌感受态细胞的制备和转化[A]..分子克隆实验指南 第2版[C].北京:科学出版社,1992.55~56.
  • 3Kamath AT, Feng CG, Macdonald M, ez d. Differential protective emcacy of DNA vaccines expressing secreted proteins of Mycohacterium Infect Immun,1999,67:1702-1704.
  • 4Vankayalapati R,Wizel B ,Weis SE, et al. Production of interleukin-18 in human tuberculosis. J Infect Dis, 2000,182 : 234 - 239.
  • 5Baldwin SL,Souza C, Roberts A D, et al. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun, 1998,66(6) :2951- 2959.
  • 6Coler. RN, Campoe-Nem A, Ovendale P, et aL. Vaccination with the T cell antigen Mth8.4 protects against challenge with Mycobacterium tubercuLosis.J Immunol, 2001, 166 : 6227 - 6235.
  • 7Coler RN, Skeiky YAW, Vedvick T, et al. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen d Mycobacterium tuberculosis.J Immunol, 1998,161:2356 - 2364.
  • 8Delogu G, Howard A, Collins FM, et al. DNA vaccination against tuberculosis: expression of a ubiquitin- conjugated tuberxulosis protein enhances antimycobacterial immunity [ J ].Infect. Immun, 2000; 68 (6): 3097 - 3102.
  • 9Baldwin SI, D' Souza C, Roberts A D, et al. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis[J]. Infect. Immun. 1998;66(6):2951 -2959.
  • 10Coler. RN, Skeiky YAW, Vedvick T, et al. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis [J]. J. Immunol,1998; 161:2356- 2364.

共引文献34

同被引文献125

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部